NVL
Nuclear valosin-containing protein-like
Also known as: NVL_HUMAN, NVL2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15381
- Gene
- NVL
- Ensembl
- ENSG00000143748
- Chromosome
- 1
- Canonical length
- 856 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli
OverviewNCBI Gene
This gene encodes a member of the AAA (ATPases associated with diverse cellular activities) superfamily. Multiple transcript variants encoding different isoforms have been found for this gene. Two encoded proteins, described as major and minor isoforms, have been localized to distinct regions of the nucleus. The largest encoded protein (major isoform) has been localized to the nucleolus and shown to participate in ribosome biosynthesis (PMID: 15469983, 16782053), while the minor isoform has been localized to the nucleoplasmin. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
856 residues, UniProt reviewed canonical sequence.
>O15381|NVL
1 MKPRPAGFVD NKLKQRVIQY LTSNKCGKYV DIGVLASDLQ RVYSIDYGRR KRNAFRIQVE
61 KVFSIISSEK ELKNLTELED EHLAKRARQG EEDNEYTESY SDDDSSMEDY PDPQSANHMN
121 SSLLSLYRKG NPDSVSNTPE MEQRETTSST PRISSKTGSI PLKTPAKDSE GGWFIDKTPS
181 VKKDSFFLDL SCEKSNPKKP ITEIQDSKDS SLLESDMKRK GKLKNKGSKR KKEDLQEVDG
241 EIEAVLQKKA KARGLEFQIS NVKFEDVGGN DMTLKEVCKM LIHMRHPEVY HHLGVVPPRG
301 VLLHGPPGCG KTLLAHAIAG ELDLPILKVA APEIVSGVSG ESEQKLRELF EQAVSNAPCI
361 IFIDEIDAIT PKREVASKDM ERRIVAQLLT CMDDLNNVAA TARVLVIGAT NRPDSLDPAL
421 RRAGRFDREI CLGIPDEASR ERILQTLCRK LRLPQAFDFC HLAHLTPGFV GADLMALCRE
481 AAMCAVNRVL MKLQEQQKKN PEMEDLPSKG VQEERLGTEP TSETQDELQR LLGLLRDQDP
541 LSEEQMQGLC IELNDFIVAL SSVQPSAKRE GFVTVPNVTW ADIGALEDIR EELTMAILAP
601 VRNPDQFKAL GLVTPAGVLL AGPPGCGKTL LAKAVANESG LNFISVKGPE LLNMYVGESE
661 RAVRQVFQRA KNSAPCVIFF DEVDALCPRR SDRETGASVR VVNQLLTEMD GLEARQQVFI
721 MAATNRPDII DPAILRPGRL DKTLFVGLPP PADRLAILKT ITKNGTKPPL DADVNLEAIA
781 GDLRCDCYTG ADLSALVREA SICALRQEMA RQKSGNEKGE LKVSHKHFEE AFKKVRSSIS
841 KKDQIMYERL QESLSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NVL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- skin: 15 nTPM
- cerebellum: 13 nTPM
- placenta: 12 nTPM
- thymus: 12 nTPM
- retina: 12 nTPM
- lymph node: 12 nTPM
Single-cell type
- myonuclei: 107 nCPM
- gonadotrophs: 97 nCPM
- distal convoluted tubule cells: 83 nCPM
- colonocytes: 78 nCPM
- choroid plexus epithelial cells: 78 nCPM
- lactotrophs: 75 nCPM
Immune cell
- non-classical monocyte: 17 nTPM
- basophil: 14 nTPM
- memory B-cell: 14 nTPM
- intermediate monocyte: 12 nTPM
- NK-cell: 12 nTPM
- memory CD4 T-cell: 12 nTPM
Brain region
- cerebellum: 16 nTPM
- white matter: 15 nTPM
- choroid plexus: 13 nTPM
- hypothalamus: 13 nTPM
- cerebral cortex: 12 nTPM
- pons: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NVL.
Disease | AutoantibodyPubMed
Conditions in which antibodies against NVL are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for NVL from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
4 publications
- Anti-nuclear valosin-containing protein-like autoantibody is associated with calcinosis and higher risk of cancer in systemic sclerosis.
2024 · Rheumatology (Oxford) · RCR 2.5 · 10 citations - Autoantibodies to nuclear valosin-containing protein-like protein: systemic sclerosis-specific antibodies revealed by in vitro human proteome.
2024 · Rheumatology (Oxford) · RCR 1.8 · 8 citations - Identification of nuclear valosin-containing-protein-like as a target of anti-nuclear autoantibodies in systemic sclerosis.
2024 · Front Med (Lausanne) · 1 citations - Development of an enzyme-linked immunosorbent assay for the efficient detection of autoantibodies against nuclear valosin-containing protein-like protein (NVL) 2 using its manipulated cDNA.
2025 · RMD Open · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.59
- DepMap mean gene effect
- -1.29
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of protein binding
- positive regulation of telomere maintenance
- regulation of protein localization to nucleolus
- ribosomal large subunit biogenesis
- ribosome biogenesis
- rRNA processing
- telomerase holoenzyme complex assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- AAA+ ATPase domain
- ATPase, AAA-type, core
- ATPase, AAA-type, conserved site
- P-loop containing nucleoside triphosphate hydrolase
- AAA ATPase, AAA+ lid domain
- AAA ATPase domain-containing protein
- ATPase family associated with various cellular activities (AAA)
- AAA+ lid domain
- NVL2, nucleolin binding domain
- NVL2, N-terminal domain superfamily
- Nucleolin binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NVL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NVL as an antibody target. Whether an autoantibody or antibody against NVL could matter depends on whether native NVL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NVL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NVL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...